Clinical Trials List
2021-05-03 - 2021-06-11
Phase III
Terminated3
ICD-10E85.0
Non-neuropathic heredofamilial amyloidosis
ICD-10E85.1
Neuropathic heredofamilial amyloidosis
ICD-10E85.2
Heredofamilial amyloidosis, unspecified
ICD-10E85.3
Secondary systemic amyloidosis
ICD-10E85.4
Organ-limited amyloidosis
ICD-10E85.8
Other amyloidosis
ICD-10E85.9
Amyloidosis, unspecified
ICD-9277.3
Amyloidosis
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shih-Hsien Sung Division of Cardiovascular Diseases
- Kon-Ping Lin Division of Neurology
- 黃偉銘 Division of Cardiovascular Diseases
- 廖若男 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- SUNG-TSANG HSIEH Division of Neurology
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
- Chi-Chao Chao Division of Neurology
- Ming-Jen Lee Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱昱偉 Division of Cardiovascular Diseases
- 蔡浩元 Division of Cardiovascular Diseases
- 林恆旭 Division of Cardiovascular Diseases
- 黃繼正 Division of Cardiovascular Diseases
- 許榮城 Division of Cardiovascular Diseases
- 曾炳憲 Division of Cardiovascular Diseases
- 莊文博 Division of Cardiovascular Diseases
- 黃姍惠 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
600 participants
